Ingen Technologies (IGNT.PK) Set to
Take Over $500 Million Market for Cannulas

Ingen Technologies, Inc. (IGNT.PK) is at a crossroads in the development of its ground-breaking smart cannulas. After years of development and preparation, the company is ready to launch its innovative product and revolutionize the $500 million cannula market!

Name: E-mail: Phone:

A Growing $500 Million per Year Market

Oxygen cannulas are used by those with chronic obstructive pulmonary disease (COPD) to increase oxygen flow and breathe easier. Approximately 23 million patients use oxygen cannulas in their home on a regular basis, while millions more use them in a hospital environment.

COPD is also a growing problem throughout the United States and abroad, as the population ages and smoking remains prominent. Deaths from COPD rose 102.8% from 1970 to 2002 and remain a problem, according to the American Cancer Society.

Since cannulas must be replaced every two or three months, there is a growing $500 million per year market for the product. Meanwhile, most of the cost is covered by a $189 per month Medicare reimbursement for oxygen tanks to treat COPD or similar problems.

Combined, this has created a growing, stable and predictable market ideal for investors.

A Market in Need of Change!

Since most in-home care providers are looking to maximize their profit margins, most oxygen cannulas now come from cheap overseas producers in countries like China. Quite simply, this is because there has been very little change in the way a cannula works… until now.

For patients, the largest concern for oxygen patients is the continuous flow of oxygen, which can be disrupted or stopped when the tank empties. If this goes unnoticed, it can lead to serious complications or even death.

For care providers, paranoid oxygen patients that believe something is wrong account for a substantial portion of support costs. Sometimes, in-home visits are even necessary to confirm that the oxygen is indeed flowing properly.

For hospitals and care providers alike, mistakes made reading oxygen tanks can also prove extremely costly in the form of malpractice lawsuits.

Ingen’s Game-Changing Cannula

Ingen Technologies (IGNT.PK) has solved these problems by building in a patented oxygen sensor that confirms the continuous flow of oxygen. The Oxyview enables patients to confirm the flow of oxygen, thereby reducing support calls and instantly alerting professionals if a problem exists.

Here’s what existing users are already saying:

“I believe this device will eliminate most of the after-hour calls we get and thus not have to send someone out to check the machine,” said Deena Neal of Professional Oxygen Supply, Inc. “Everyone in this industry is looking for ways to reduce costs and I think [Ingen’s Oxyview] will be a great way to help with that.”

“For less money than [our patient’s] trip to the emergency room cost, we bought enough Oxyviews to ensure every one of the nursing home residents has flow in their cannulas,” said Dr. Gary Call. “[Moreover], no longer does our staff have to lean down and lift the tank out of its bracket, let it find a balance point, before determining whether or not oxygen is available.”

Hospitals

Hospitals are already beginning to adopt Ingen’s unique cannulas…

Dr. Gary Call, Chief Medical Officer of Bingham Memorial Hospital in Blackfoot, Idaho, purchased Ingen’s Oxyview cannulas to ensure that every one of the nursing home residents has oxygen flow after experiencing a problem with an empty tank earlier.

Government

On January 28th, Ingen announced that it had officially signed a contract with Texas-based KGMA Business solutions for pursuing U.S. Government contracts.

The firm had prepared and submitted the GSA application for Ingen on September 22, 2009, which if approved, could open the door to more than 300 VA hospitals in the U.S.

International

On February 8th, Ingen announced that it passed Stage-I of its ISO 13485 Certification audit that is necessary to open international sales channels where it already has a substantial backlog and distribution partners lined up.

The company plans to finish the final Stage-II audit on March 1, 2010 and meet its 2010 projects of $11 million in sales.

In The News

Ingen CEO Scheduled for Talk Radio Interview (May 24, 2010)
Ingen CEO Scheduled for Talk Radio Interview (May 21, 2010)
Ingen Captured the Show as Best Product Featured at Medtrade (May 19, 2010)
KGMA Reels-In $1M in Government Contracts Over Next 3 Months (May 6, 2010)
World Broadcast of MedTrade TV Features Ingen (May 5, 2010)
Ingen CEO National Televised Broadcast on The Money Show (Apr 29, 2010)
Letter From the Chairman of Ingen Technologies (Apr 27, 2010)

Explosive Near-term Catalysts

Ingen stands at a key reflex point in its history after having developed a unique solution to a growing problem in a $500 million per year market.
Ingen’s contract with KGMA will help it expand its products into 300 VA hospitals in the U.S., which could quickly ramp up sales.
Ingen’s ISO 13485 Stage-II completion – expected in March 2010 – will help it expand into international markets where it already has backlogged orders.

Complete the Form Below or Call 888-288-5215 to Learn More!
Name: E-mail: Phone:
 
 

TheOTCInvestor.com (herein referred to as “us”, “we” or “the website”) is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. All information that we provide is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Furthermore, investing in such securities involves substantial risk of loss and investors should seek advice from financial professionals before investing.

Our Content

TheOTCInvestor.com, the owner, publisher, editor and their associates work diligently to ensure that all facts are correct and free from error, but we are not responsible for errors and omissions. TheOTCInvestor.com and its associates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice.

Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that the investor’s entire investment may be lost or impaired due to the speculative nature of the companies listed.

TheOTCInvestor.com makes no recommendation that the securities of the companies listed should be purchased, sold or held by individuals or entities that learn of the listed companies through TheOTCInvestor.com.

Readers are encouraged to consult a broker before purchasing or selling any securities mentioned on TheOTCInvestor.com. We recommend that readers use the information found within its properties as a starting point for conducting their own research on the featured company in order to determine their own personal opinion of the company before investing. TheOTCInvestor.com is not liable for any investment decisions made by our readers. Readers should investigate and fully understand all risks before investing.

Safe Harbor Statement

This website contains such “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements in connection with any discussion of future operating or financial performance are identified by use of words such as “may,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning. Such statements are based on our expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such forward-looking statements.

Any statements that express or involve predictions, expectations, plans, beliefs, objectives, projections, future events, goals, or performance may be forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, intense competition, adverse economic conditions, termination of contracts or agreements, inadequate capital, lack of meaningful research results, inability to carry out research and development plans, loss of key personnel, and other risks detailed in the reports filed by the Securities and Exchange Commission by companies that are featured on our properties.

In light of these assumptions, risks and uncertainties, the results and events discussed in the forward-looking statements contained in this website or in any document accessible from this website might not occur. Stockholders are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this posting or the date of the document(s) accessible from this website. We are not under any obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. All subsequent forward-looking statements attributable to us or to any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section.

Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein. More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at http://www.sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.

Third Party Links

TheOTCInvestor.com and our newsletter may provide hyperlinks to third party websites or access to third party content. We do not control, endorse or guarantee content found in such sites. By accessing, viewing or using the website or communications originating from the website, you agree that TheOTCInvstor.com, operators, owners and employees, are not responsible for any content, associated links, resources or services associated with a third party website.

Compensation

TheOTCInvestor.com may receive compensation from companies listed or from firm’s working on behalf of the companies listed in the “Research” section of our website. If such compensation is presented, a notice will appear at the end of the affected article. The nature and amount of compensation can be found at the bottom of this disclaimer. TheOTCInvestor.com and its officers, directors and employees may also have bought or sold or may buy or sell shares in the companies discussed within the website. View Full Disclaimer

Your Agreement

By viewing or using this website, you agree to hold TheOTCInvestor.com, its operators, owners and employees, and furthermore, you agree to completely release TheOTCInvestor.com, its operators, owners and employees from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise) or injury (monetary or otherwise) that you may incur.